Glucose & Insulin

Nevada Bill Would Track Insulin Profits

Nevada is considering legislation that would track the profits pharmaceutical companies make on sales of insulin. It’s a move hailed by many patients with diabetes – yet patient advocacy groups have had little to say on the subject. Read more

Will Apple Watch Soon be Tracking Your Glucose?

It looks like Apple’s attempt to integrate glucose-tracking technology into the Apple Watch may be getting closer to reality. CEO Tim Cook appears to be personally testing the device, which could make staying on top of blood sugar levels much easier for many diabetes patients. Read more

New Program Seeks to Empower Self-Management

Diabetes is widespread in the U.S. More than  eight million Americans have the disease, and treatment costs each year exceed $320 billion. A new program in San Diego using innovative strategies to improve health and reduce the cost of diabetes by encouraging better self-management of the disease. Read more

Studies indicate patient knowledge of personal A1C level fosters better long-term health outcomes

Diabetes patients who receive immediate feedback on their A1C levels are better able to improve their glycemic control, which in turn reduces their risk of developing long term complications associated with diabetes. A decade long study entitled the Diabetes Control and Complications Trial (DCCT), conducted from 1982 to 1993, tested the hypothesis whether complications associated […]

Smartphones May Learn to Speak to Cells

Researchers have demonstrated a new system in which a smartphone is used to tell engineered cells implanted in diabetic mice to produce insulin. The closed-loop system uses a digital glucometer to transmit data on the rodents’ blood glucose levels to a smartphone. The smartphone processes the data and then signals the implanted cells to deliver insulin. […]

Silicon Valley Looks for Non-Invasive Way to Monitor Blood Sugar

Many life sciences companies have tried to develop sensors that can monitor blood sugar without drawing blood, but so far none has succeeded. Now, Silicon Valley is taking on the challenge, with Apple looking to solve the problem. The company has a team of about 30 people in an office in Palo Alto working on a project […]

FreeStyle Libre Use Associated with Better Glucose Control

Researchers found that Libre users checked their glucose readings an average of 16 times a day; that’s about three times the amount of fingerstick checks that medical professionals recommend for people with Type 1 diabetes, according to Tim Dunn, an Abbott associate research fellow connected with the analysis. The Libre differs from a continuous glucose […]

diaTribe – How to Get More Strips on a Budget

Here are some tips for getting more test strips at a lower cost, either through insurance or by paying cash.

Basal Insulin Tresiba Approved for Teens and Kids as Young as One

Novo Nordisk recently announced FDA approval of an expanded pediatric indication for Tresiba, meaning that the basal insulin can now be used to treat people with type 1 and type 2 diabetes as young as age one. The label update is based on data from the BEGIN YOUNG 1 trial, which showed Tresiba is safe […]

A New Combination Treatment Could Become the Standard T2 Diabetes

A study in Diabetes Care showed that patients with poorly controlled type 2 diabetes who received a combination of exenatide and pioglitazone had a threefold lower rate of hypoglycemia, a one-percentage-point greater reduction in A1C and less weight gain than those in the basal-bolus insulin therapy group.

How Afrezza Inhaled Insulin Makes My Life Better

Afrezza, invented by MannKind, a Connecticut-based pharmaceutical company, is the only inhalable insulin in existence. It’s actually been on the market once before. When it was first launched, about a decade ago, the apparatus to take the insulin was so giant and ill conceived that some likened it to a bong. The new inhaler is […]

Diabetes Tech ‘Spectations for 2017

We’ve been listening to earnings calls and talking with company execs, industry insiders and PR teams to get a sense of what else is on the horizon, compiled in the following report.

2016: A Pivotal Year for Closed Loop/Automated Insulin Delivery

In September, the FDA approved the first hybrid closed-loop system for automating insulin delivery to reduce both highs and lows: Medtronic’s MiniMed 670G system including the latest Guardian Sensor 3 CGM. The milestone approval came after an unexpectedly fast three-month FDA review, and just four months after Medtronic reported positive data from its three-month home […]

Bluetooth insulin dose device helps users keep track of their injections

A new Bluetooth insulin dose tracker, called Insulog, can be fitted onto most existing insulin pens to prevent dose errors in people with type 1 diabetes and insulin-treated type 2 diabetes. The device, created by a Tel Aviv-based startup, is the object of an online crowdfunding campaign recently launched on Indiegogo.

Device ‘Hassle’ Deters Use in Some Type 1 Diabetes Patients

Perception of “hassle” is the most common modifiable barrier keeping people with type 1 diabetes from choosing to wear insulin pumps and continuous glucose monitors (CGMs), new research indicates.

6 New Diabetes Products to Look for in 2017

We’ve rounded up descriptions of some of the most exciting diabetes products expected to hit the market in 2017, followed by an approximate timeframe of when they’ll become available to the public. Sure, what we really want is a cure in 2017, but we’ll take improved quality of life, thanks to new devices and tech, […]

DiabetesMine – On Pharma and Employers in the Insulin Affordability Crisis

We reported earlier this week about a landmark roundtable gathering of diabetes advocates and industry leaders in Washington D.C. to address the complex problem of insulin affordability and access here in the U.S.

Are PBMs Driving Up The Price of Insulin?

PBMs are organizations commonly understood to be the “middle men” in the chain of distribution of prescription drugs and medical devices from the manufacturers to the places where those products are dispensed or purchased through an insurance carrier or a prescription purchase plan. They are also considered the organizations to which health insurance carriers outsource […]

Dexcom’s G6 Sensor Shines in Early Accuracy Study

Earlier this month, Dexcom shared compelling new details on its longer-wear, less calibration G6 sensor and its partnership with Verily to develop a bandage-like continuous glucose monitoring (CGM) device. The G6 sensor is expected to launch in 2018, while the first-gen Verily sensor will launch in late 2018, with a second-gen version coming as early […]

MannKind Markets Afrezza to People with Type 1 Diabetes

The maker of inhaled insulin Afrezza is betting that relaunching their product and making it a success depends less on diabetics being afraid of needles and more on its clinical advantages over existing insulin.